C. Daniel
Haaren

Mr. Haaren’s clients have included ADT, Albemarle, Ashland, Bank of America, Barclays, BDT Capital Partners, Booking Holdings, Brunswick, Cable One, Cincinnati Bell, Cinemark, Citigroup, Conduent, Credit Suisse, Deutsche Telekom, FactSet Research Systems, Gannett, Goldman Sachs, Illumina, J.P. Morgan, John Wood Group, Martin Marietta, MediaAlpha, Morgan Stanley, Olin, PG&E, Pinnacle Foods, Radius Global Infrastructure, Robinhood, Shaolin Capital Management, Swvl, Technicolor, US Foods, ViewRay, Wells Fargo and White Mountains Insurance Group.

Mr. Haaren’s notable financing transactions include:

• IPOs for Core & Main, Groupe Dynamite, MediaAlpha and Valvoline, and other equity offerings for ADT, Albemarle, Algonquin Power & Utilities, AmerisourceBergen, Core & Main, First Horizon Bank, Hewlett Packard Enterprise, LPL Financial, MediaAlpha, PG&E and ViewRay
• Investment grade debt offerings for Aptiv, Ascot Group, Ashland, Booking Holdings, Brunswick, CNA, ConocoPhillips, Enstar, Entegris, Expedia, FactSet Research Systems, Fidelis Insurance Group, First Horizon Bank, Gannett, Illumina, Jersey Central Power & Light, JPMorgan Chase, KLA, Liberty Utilities, LPL Financial, Markel, Northrop Grumman, nVent Electric, PartnerRe, Pennsylvania Electric Company, Pentair, Seaspan, Sherwin‑Williams and Sonoco
• Convertible debt offerings for Allegheny Technologies, Booking Holdings, Cable One, Cinemark, Eventbrite, FirstEnergy, Gannett, Magnite, Oddity, Peloton, Uniti and Xerox
• High‑yield debt offerings for Ashland, Entegris, First Student and First Transit (in connection with their acquisition by EQT), FirstEnergy, FirstEnergy Transmission, Gannett, Gulfport Energy, Olin, Seaspan and Tesoro
• Bristol Myers Squibb’s investments in biotechnology companies including Asher Bio, COUR Pharmaceuticals and Q32 Bio

• Representing Shaolin Capital Management in its $50 million PIPE investment in connection with the business combination of Bitcoin Depot and GSR II Meteora Acquisition Corp.
• Representing Swvl in its $1.5 billion SPAC combination with Queen’s Gambit, including a $111.5 million PIPE investment and a $471.7 million equity financing facility
• Representing Robinhood in its $3.4 billion capital raise and its $605.7 million purchase from the United States Marshals Service of shares previously owned by Emergent Fidelity Technologies, a firm co‑founded by FTX founder Sam Bankman‑Fried
• Representing PG&E in its $9 billion equity exit financing, including its tri‑tranche offering, which represents the largest utility public equity offering in history, and corporate governance and securities law compliance matters related to PG&E’s reorganization proceedings under chapter 11
• SPAC IPOs for Climate Transition Capital Acquisition 1, GoGreen Investments and Nabors Energy Transition Corp.

Mr. Haaren was named a “Rising Star” by Law360 in 2021, recognizing him as one of five outstanding capital markets lawyers in the nation under the age of 40, and received Euromoney Legal Media Group’s 2022 Americas Rising Star Award for “Best in Equity Capital Markets.” He has been recognized for his work in capital markets by The Legal 500 US and has been recognized by Lawdragon as among the “500 Leading Dealmakers in America” and the “500 X – The Next Generation.” Mr. Haaren also presents on developments in corporate and capital markets law, having participated in events such as TechGC’s First‑Time GC Summit and the International Bar Association’s Annual Conference. He was selected to serve as a member of Law360’s Capital Markets Editorial Advisory Board in 2023.

Mr. Haaren received a B.A. from Duke University in 2009 and a J.D. magna cum laude from the New York University School of Law in 2012, where he was an Articles Editor of the Law Review and elected to the Order of the Coif.

Mr. Haaren joined Cravath in 2012 and was elected a partner in 2019. He currently serves as Corporate Hiring Partner and is a member of the Diversity Committee.